Neurotron Neurometer CPT Neuro-Selective Diagnostic Stimulator MM3, US $2,499.95 – Picture 0

Neurotron Neurometer CPT Neuro-Selective Diagnostic Stimulator MM3, US $2,499.95 – Picture 1

Neurotron Neurometer CPT Neuro-Selective Diagnostic Stimulator MM3, US $2,499.95 – Picture 2

Neurotron Neurometer CPT Neuro-Selective Diagnostic Stimulator MM3, US $2,499.95 – Picture 3

Neurotron Neurometer CPT Neuro-Selective Diagnostic Stimulator MM3, US $2,499.95 – Picture 4

Neurotron Neurometer CPT Neuro-Selective Diagnostic Stimulator MM3, US $2,499.95 – Picture 5

Neurotron Neurometer CPT Neuro-Selective Diagnostic Stimulator MM3, US $2,499.95 – Picture 6

Neurotron Neurometer CPT Neuro-Selective Diagnostic Stimulator MM3, US $2,499.95 – Picture 7

Neurotron Neurometer CPT Neuro-Selective Diagnostic Stimulator MM3, US $2,499.95 – Picture 8

Neurotron Neurometer CPT Neuro-Selective Diagnostic Stimulator MM3, US $2,499.95 – Picture 9

Neurotron Neurometer Cpt Neuro-selective Diagnostic Stimulator Mm3

US $2,499.95

Columbia, South Carolina, United States
Jan 30th

Open on mobile:
QR code

Neurotron Neurometer CPT Neuro-Selective Diagnostic Stimulator MM3. In excellent working condition. The battery was tested and is working. Accessories included are shown in the pictures. 14 Day money back guarantee! The Neurometer is a portable electrodiagnostic sensory nerve conduction threshold testing device. Neurometer tests are painless and may be conducted anywhere on the surface of the body - including the most distal cutaneous finger and toe sites permitting the earliest possible detection of sensory nerve damage resulting from conditions such as diabetes, carpal tunnel syndrome, spinal injury, sciatica, and radiculopathy, and polyneuropathy. With the Neurometer one can conduct a Current Perception Threshold (CPT) examination which is an ideal replacement for painful and dangerous procedures hampered by low patient compliance. The CPT evaluation permits the determination of neurological dysfunction from hyperesthesia/neuritis through hypoesthesia/neuropathy as well as monitoring the progression of nerve regeneration. FDA DISCLAIMER "The sale of this item may be subject to regulation by the U.S. Food and Drug Administration and state and local regulatory agencies. If so, do not bid on this item unless you are an authorized purchaser. If the item is subject to FDA regulation, I will verify your status as an authorized purchaser of this item before shipping of the item."